Editorial Comment from Dr Matsuo et al. to Mirabegron for treatment of erectile dysfunction concomitant with lower urinary tract symptoms in patients with benign prostatic obstruction: A randomized controlled trial

Int J Urol. 2022 May;29(5):397. doi: 10.1111/iju.14820. Epub 2022 Feb 10.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Comment

MeSH terms

  • Acetanilides / therapeutic use
  • Erectile Dysfunction* / drug therapy
  • Erectile Dysfunction* / etiology
  • Humans
  • Lower Urinary Tract Symptoms* / drug therapy
  • Lower Urinary Tract Symptoms* / etiology
  • Male
  • Prostatic Diseases*
  • Thiazoles / therapeutic use

Substances

  • Acetanilides
  • Thiazoles
  • mirabegron